Q3 2025 Earnings Call Transcript March 11, 2025 Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.3181 ...

PharmaCord is a Jeffersonville, Indiana-based provider of patient services for the biopharmaceutical industry, and Mercalis, a Morrisville, North Carolina-based provider of life sciences and ...

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $11.29 and traded as high as $13.45.

Rhumbline Advisers increased its position in Can-Fite BioPharma Ltd. (NYSE:CANF – Free Report) by 58.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...

The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

We recently published a list of Top 10 Stocks Everyone Is Talking About These Days. In this article, we are going to take a ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.